TPO11_CANGA
ID TPO11_CANGA Reviewed; 567 AA.
AC Q6FTB1;
DT 28-FEB-2018, integrated into UniProtKB/Swiss-Prot.
DT 19-JUL-2004, sequence version 1.
DT 03-AUG-2022, entry version 93.
DE RecName: Full=Multidrug transporter TPO1_1 {ECO:0000303|PubMed:26512119};
DE AltName: Full=Clotrimazole exporter TPO1_1 {ECO:0000303|PubMed:26512119};
DE AltName: Full=Drug:H(+) antiporter TPO1_1 {ECO:0000303|PubMed:27148215};
DE Short=DHA TPO1_1 {ECO:0000303|PubMed:27148215};
GN Name=TPO1_1 {ECO:0000303|PubMed:26512119}; OrderedLocusNames=CAGL0G03927g;
OS Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL
OS Y-65) (Yeast) (Torulopsis glabrata).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC Saccharomycetales; Saccharomycetaceae; Nakaseomyces;
OC Nakaseomyces/Candida clade.
OX NCBI_TaxID=284593;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65;
RX PubMed=15229592; DOI=10.1038/nature02579;
RA Dujon B., Sherman D., Fischer G., Durrens P., Casaregola S., Lafontaine I.,
RA de Montigny J., Marck C., Neuveglise C., Talla E., Goffard N., Frangeul L.,
RA Aigle M., Anthouard V., Babour A., Barbe V., Barnay S., Blanchin S.,
RA Beckerich J.-M., Beyne E., Bleykasten C., Boisrame A., Boyer J.,
RA Cattolico L., Confanioleri F., de Daruvar A., Despons L., Fabre E.,
RA Fairhead C., Ferry-Dumazet H., Groppi A., Hantraye F., Hennequin C.,
RA Jauniaux N., Joyet P., Kachouri R., Kerrest A., Koszul R., Lemaire M.,
RA Lesur I., Ma L., Muller H., Nicaud J.-M., Nikolski M., Oztas S.,
RA Ozier-Kalogeropoulos O., Pellenz S., Potier S., Richard G.-F.,
RA Straub M.-L., Suleau A., Swennen D., Tekaia F., Wesolowski-Louvel M.,
RA Westhof E., Wirth B., Zeniou-Meyer M., Zivanovic Y., Bolotin-Fukuhara M.,
RA Thierry A., Bouchier C., Caudron B., Scarpelli C., Gaillardin C.,
RA Weissenbach J., Wincker P., Souciet J.-L.;
RT "Genome evolution in yeasts.";
RL Nature 430:35-44(2004).
RN [2]
RP DISRUPTION PHENOTYPE, FUNCTION, SUBCELLULAR LOCATION, AND INDUCTION.
RX PubMed=26512119; DOI=10.1074/mcp.m114.045344;
RA Pais P., Costa C., Pires C., Shimizu K., Chibana H., Teixeira M.C.;
RT "Membrane proteome-wide response to the antifungal drug clotrimazole in
RT Candida glabrata: role of the transcription factor CgPdr1 and the drug:H+
RT antiporters CgTpo1_1 and CgTpo1_2.";
RL Mol. Cell. Proteomics 15:57-72(2016).
RN [3]
RP FUNCTION.
RX PubMed=27148215; DOI=10.3389/fmicb.2016.00526;
RA Costa C., Ribeiro J., Miranda I.M., Silva-Dias A., Cavalheiro M.,
RA Costa-de-Oliveira S., Rodrigues A.G., Teixeira M.C.;
RT "Clotrimazole drug resistance in Candida glabrata clinical isolates
RT correlates with increased expression of the drug:H(+) antiporters CgAqr1,
RT CgTpo1_1, CgTpo3, and CgQdr2.";
RL Front. Microbiol. 7:526-526(2016).
RN [4]
RP DISRUPTION PHENOTYPE, AND FUNCTION.
RX PubMed=27780306; DOI=10.1111/cmi.12686;
RA Santos R., Costa C., Mil-Homens D., Romao D., de Carvalho C.C., Pais P.,
RA Mira N.P., Fialho A.M., Teixeira M.C.;
RT "The multidrug resistance transporters CgTpo1_1 and CgTpo1_2 play a role in
RT virulence and biofilm formation in the human pathogen Candida glabrata.";
RL Cell. Microbiol. 19:0-0(2017).
CC -!- FUNCTION: Multidrug resistance transporter involved in resistance to
CC azole antifungal drugs such as the imidazoles miconazole, ketoconazole,
CC and tioconazole; as well as the triazoles itraconazole and fluconazole
CC (PubMed:26512119). Also plays a role in the resistance to other
CC antifungal drug families such as the polyene amphotericin B, the
CC pyrimide analog flucytosine, the fungicide mancozeb, and the polyamine
CC spermine (PubMed:26512119). Decreases the intracellular accumulation of
CC clotrimazole by mediating its extrusion from cells (PubMed:26512119,
CC PubMed:27148215). Involved in virulence by confering resistance to the
CC human antimicrobial peptide histatin-5 (PubMed:27780306).
CC {ECO:0000269|PubMed:26512119, ECO:0000269|PubMed:27148215,
CC ECO:0000269|PubMed:27780306}.
CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:26512119};
CC Multi-pass membrane protein {ECO:0000255}.
CC -!- INDUCTION: Expression is up-regulated by clotrimazole
CC (PubMed:26512119). {ECO:0000269|PubMed:26512119}.
CC -!- DISRUPTION PHENOTYPE: Leads to intracellular accumulation of
CC clotrimazole and increases the susceptibility to clotrimazole but also
CC to other imidazoles such as miconazole, ketoconazole, and tioconazole;
CC as well as triazoles such as itraconazole and fluconazole
CC (PubMed:26512119). Increases also susceptibility to other antifungal
CC drug families such as the polyene amphotericin B, the pyrimide analog
CC flucytosine, the fungicide mancozeb, and the polyamine spermine
CC (PubMed:26512119). Decreases virulence in a Galleria mellonella model
CC of infection (PubMed:27780306). {ECO:0000269|PubMed:26512119,
CC ECO:0000269|PubMed:27780306}.
CC -!- SIMILARITY: Belongs to the major facilitator superfamily. DHA1 family.
CC Polyamines/proton antiporter (TC 2.A.1.2.16) subfamily. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CR380953; CAG59460.1; -; Genomic_DNA.
DR RefSeq; XP_446533.1; XM_446533.1.
DR AlphaFoldDB; Q6FTB1; -.
DR STRING; 5478.XP_446533.1; -.
DR EnsemblFungi; CAG59460; CAG59460; CAGL0G03927g.
DR GeneID; 2888403; -.
DR KEGG; cgr:CAGL0G03927g; -.
DR CGD; CAL0137711; TPO1_1.
DR VEuPathDB; FungiDB:CAGL0G03927g; -.
DR eggNOG; KOG0255; Eukaryota.
DR HOGENOM; CLU_008455_11_4_1; -.
DR InParanoid; Q6FTB1; -.
DR PHI-base; PHI:6625; -.
DR Proteomes; UP000002428; Chromosome G.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0005886; C:plasma membrane; IDA:CGD.
DR GO; GO:0022857; F:transmembrane transporter activity; IEA:InterPro.
DR Gene3D; 1.20.1250.20; -; 1.
DR InterPro; IPR011701; MFS.
DR InterPro; IPR020846; MFS_dom.
DR InterPro; IPR036259; MFS_trans_sf.
DR Pfam; PF07690; MFS_1; 1.
DR SUPFAM; SSF103473; SSF103473; 1.
DR PROSITE; PS50850; MFS; 1.
PE 2: Evidence at transcript level;
KW Cell membrane; Glycoprotein; Membrane; Reference proteome; Transmembrane;
KW Transmembrane helix; Transport; Virulence.
FT CHAIN 1..567
FT /note="Multidrug transporter TPO1_1"
FT /id="PRO_0000443414"
FT TRANSMEM 128..148
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 157..177
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 194..214
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 224..244
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 253..273
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 283..303
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 358..378
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 396..416
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 436..456
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 471..491
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 498..520
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TRANSMEM 531..551
FT /note="Helical"
FT /evidence="ECO:0000255"
FT REGION 1..71
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 10..32
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 44..69
FT /note="Polar residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT CARBOHYD 120
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00498"
SQ SEQUENCE 567 AA; 62560 MW; D2B173C5C7B0F47F CRC64;
MVEEISPKYT NEQAEASSSS SSSVSGEPKD FSGSLENQED LGELIERTNT MTSGAESKVE
TNRRMSRILT GTQDDPEKIA IDYSNCPPMG GDRPFPPALP EQSQFEVTFD GPNDPIHPFN
WSMKTKTIIC IVLCLNCICI SMGSSIFASG VPQICKIYHV IPVVAILGVT LYVFGFAASP
VIYAPLSEVY GRRGVLVISA FGFAVFQFAV ATSKDLQSIM ICRFFGGLIG AAPMAVVPAA
FADMFDVRVR GKAICLFSLG VFVGPILSPV MGSYIAQRTT WRWLEYVTGC FASALFVAVA
LTFKETHHPT ILVQKAKEMR KSTNNWGIHA AHEHVELSVS EIAKKTITRP IKMLFTEPLL
LIITIYNSFV YGILYLMLEA YPIVFVEGYG FEANGELPYI ALIIGMLVCT AFLWYFENDY
LKRIQKAGKL VPEARLIPMV YAGVIFPIGI LWFCWTGYYP HKIHWMCPTV AGSFIGFGLM
GIFLPCLNYI IESYLPLAAS AVAANTFMRS AFGAVFPLFA GYMFHGMGTG WAGLLLGLFA
AALIPVPLFF LKYGERIRKN SKDAYYA